Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

NCT00106028 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: risedronate sodium (Actonel)
DRUG: Placebo

Sponsor

Warner Chilcott